Therapeutics Acquisition Corp. (TXAC), announced the pricing of their upsized $118 million SPAC IPO this afternoon and the shares are currently trading under the symbol Nasdaq: TXAC.
Therapeutics Acquisition Corp. is being sponsored by RA Capital Management, L.P., and is being led by Chairman and CEO Peter Kolchinsky PhD, and CFO Matthew Hammond PhD.
Total SPAC deal count for 2020 year-to-date is now 39 with $12.319 billion in gross proceeds raised. The offering is anticipated to close on Friday, July 10, 2020.
Jefferies LLC acted as sole book-running manager for the offering. Goodwin Procter LLP and White & Case LLP were Issuer’s Counsel and Underwriter’s Counsel, respectively. WithumSmith+Brown, PC, acted as auditor.
At the SPAC of Dawn Since closing its combination with DHC last month, AI customer engagement firm BEN (NASDAQ:BNAI) has rolled out new partnerships with call center and healthcare clients. And, while it faces a fair bit of competition in the chatbot realm, several high-profile institutions have demonstrated that creating one that provides useful services...
Blue Ocean (NASDAQ:BOCN) provided significantly more texture today in the presentation for its $275 million combination with Asian digital media group TNL Mediagene, which it expects to hit profitability in the second half of the year despite a slight shakeup in financing for the transaction. The first big update in the first investor deck is...
At the SPAC of Dawn A brand new market may have just opened up for space de-SPACs as NASA administrator Bill Nelson announced a shift in the agency’s $11 billion program for a mission to return samples from Mars. Rather than rely on the agency’s internal technologies that would be predicted to get a sample...
Overall deal flow between SPACs and biotech firms has slowed over the last year, but some pending FDA changes could breathe new life into particular business models within the space. In particular, the FDA has asked Congress as part of its 2025 Legislative Proposals to eliminate the interchangeability designation for biosimilar medications, claiming the existing...
At the SPAC of Dawn Ever since Digital World announced its combination with Trump Media (NASDAQ:DJT) back in October 2021, it was clear that SPACworld and the Trump show were set to be intertwined for quite some time. And, although not every headline has a bearing on the wider SPAC world, Trump Media’s post-close rise...